Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sacco System operates globally as a leading provider of probiotic cultures, live biotherapeutics, postbiotics, enzymes, rennet, and related ingredients. It supports clients from R&D through process validation to full-scale GMP manufacturing. The company’s proprietary strains are used in food fermentation as well as pharmaceutical/nutraceutical products. No clinical trial results are published directly by the company—it acts primarily as an enabler/CDMO for client programs.
CSL within the group was the first Italian company to study lactic acid bacteria for human use. The group has cGMP-certified facilities supporting drug development up to commercial production of live biotherapeutics.
Pipeline details are not public since it does not develop its own therapeutics but enables others’ pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sacco System.